ACM
EXAS

ADAR1 Capital Management’s Exact Sciences EXAS Stock Holding History

ADAR1 Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,000
Closed -$216K – 219
2025
Q1 		$216K Hold
5,000
– – 0.04% 143
2024
Q4 		$281K Sell
5,000
-10,200
-67% -$635K 0.06% 138
2024
Q3 		$1.04M Buy
15,200
+14,600
+2,433% +$824K 0.17% 73
2024
Q2 		$25.4K Sell
600
-1,100
-65% -$60.5K ﹤0.01% 211
2024
Q1 		$117K Buy
+1,700
New +$108K 0.03% 142

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

ADAR1 Capital Management's EXAS Position: Q2 2025 in Review

ADAR1 Capital Management sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 5,000 shares — an estimated $216K sold.

ADAR1 Capital Management first reported a position in EXAS in Q1 2024 and held it in 5 quarters. The position peaked at $1.04M in Q3 2024. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • ADAR1 Capital Management reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • ADAR1 Capital Management sold 5,000 Exact Sciences shares in Q2 2025, an estimated $216K.
  • ADAR1 Capital Management first reported a position in Exact Sciences in Q1 2024 and held it in 5 quarters.
  • ADAR1 Capital Management's Exact Sciences position peaked at $1.04M in Q3 2024.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on ADAR1 Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.